Brief statements: Defective DNA damage response (DDR) can result in genomic instability (GIN) which is considered to be a central aspect of any carcinogenic process. P53-binding protein 1 (53BP1) belongs to a family of evolutionarily conserved DDR proteins. This study demonstrated a number of nuclear 53BP1 foci in human skin tumorigenesis, suggesting a constitutive activation of DDR in skin cancer cells. The results of this study suggest that GIN has a crucial role in the progression of skin carcinogenesis. Naruke et al. 3 
Introduction
The skin is the primary barrier for humans against the external environment.
Therefore, epidermal cells are the first cells to be exposed to physical and chemical genotoxic agents such as ultraviolet (UV) and ionizing radiations (IR). IR effectively induces DNA double strand breaks (DSBs) in normal cells and activates DNA damage response (DDR) pathways to maintain genomic integrity. DDR genes, such as p53, are frequently mutated in human cancer. Thus, defective DDR can result in genomic instability (GIN) which is generally considered to be a central aspect of any carcinogenic process. (1, 2) It has been shown that gamma irradiation induced skin tumors in mice. Most of the tumor-bearing mice showed a loss of the wild-type p53 allele.
Since no skin tumor was found in wild-type p53 mice, this suggested a requirement of p53 loss in irradiation-induced skin carcinogenesis. (3) The incidence of skin cancer was reported to be elevated in atomic bomb survivors, which also suggested a radiation etiology in human skin carcinogenesis. (4) P53-binding protein 1 (53BP1) belongs to a family of evolutionarily conserved DDR proteins with C-terminal BRCT domains. (5, 6) The 53BP1 is a nuclear protein that rapidly localizes at the sites of DSBs, and co-operatively activates p53 with other kinases. (7) (8) (9) (10) (11) (12) Subsequently, activated p53 plays a critical role in cellular responses to genomic injury, such as cell cycle arrest, DNA repair, and apoptosis. (13, 14) It has been well documented in vitro with immunofluorescence that 53BP1 exhibits diffuse nuclear staining in untreated primary cells. However, after exposure to IR, 53BP1 localizes at the sites of DSBs and forms discrete nuclear foci. (7, 8, 15, 16) We have recently demonstrated that immunofluorescence analysis for 53BP1 specifically detected the 53BP1 nuclear foci at the sites of DSBs induced by IR in formalin-fixed paraffin-embedded mouse intestine. (17) Because one manifestation of GIN is the induction of endogenous DSBs, (18) the level of 53BP1-focus formation can be considered as a cytological marker for GIN.
Human cancers develop through a multistep process that involves the accumulation of genetic mutations. (19) It is well established that any DNA damages can lead to GIN and subsequently induce DDR. Thus, measurement of GIN, a hallmark feature of solid tumors that is implicated in both initiation and progression of cancers, may serve as a valuable molecular marker of malignant potential. Our recent study of thyroid tumors from patients demonstrated a few nuclear 53BP1 foci in follicular adenoma but conspicuously more nuclear 53BP1 foci in thyroid cancers. This suggested a constitutive activation of DDR in thyroid tumors and increased GIN with progression of cancer. (17) Furthermore, anaplastic thyroid cancers prominently exhibited an abnormal and intense nuclear staining of 53BP1, which was also observed in mouse colonic crypts as a delayed response to a lethally high dose of IR, suggesting increased GIN with progression to high-grade cancer. (17) Thus, we propose that immunofluorescence analysis of 53BP1 expression can be a useful tool to estimate the level of GIN and, simultaneously, the malignant potential of human thyroid tumors. The present study analyzed the presence of GIN by immunofluorescence of 53BP1 expression in a series of skin tissues from patients to evaluate the significance of GIN during skin carcinogenesis. Similar to thyroid tumorigenesis, GIN was shown to be induced in skin cells at a precancerous stage and increased significantly with progression to cancer.
Subjects and Methods

Skin tumor tissues
A total of 56 archival skin tissue samples, which were obtained from surgically excised specimens, were selected for this study from the archives of our department (Table 1) . Histologically, the 56 primary skin tumors were comprised of the following:
20 seborrheic keratosis (SK) arising from 10 sun-exposed (including 7 faces and 3 necks) and 10 non-exposed sites (including 4 abdomens, 3 chests, 2 axillae, and 1 backs); 8 actinic keratosis (AK); 9 Bowen's disease (BD); 9 squamous cell carcinoma (SCC); and 10 basal cell carcinoma (BCC). All samples were formalin-fixed paraffin-embedded tissues, from which sections were prepared for immunofluorescence studies. For normal controls, 14 samples of non-exposed (including 5 abdomens, 5
backs, 2 ramps, 1 chest, and 1 axilla) and 8 samples of sun-exposed (including 5 faces, 1 neck, 1 hand, and 1 leg) normal epidermal cells surrounding tumor sections were evaluated.
Immunofluorescence
After antigen retrieval with microwave treatment in citrate buffer, deparaffinized sections were preincubated with 10% normal goat serum. Tissue sections were then reacted with anti-53BP1 rabbit polyclonal antibody (Bethyl Labs, Montgomery, TX, USA) at a 1:200 dilution. The slides were subsequently incubated with Alexa Fluor 488-conjugated goat anti-rabbit antibody (Invitrogen, Carlsbad, CA, USA). Specimens were counterstained with 4', 6-diamidino-2-phenylindole dihydrochloride (DAPI-I, Vysis Inc.), and were visualized and photographed using a fluorescence microscope (Zeiss Axioplan2, Carl Zeiss Japan, Tokyo, Japan) equipped with a CCD camera, and then analyzed with IPLab/MAC image software (Scanalytics Inc., Fairfax, VA). Signals were analyzed in 10 viewing areas per case at a 1,000-fold magnification.
Evaluation of immunofluorescence results
As described in our previous report, (17) 
Statistical analysis
The Mann-Whitney test was used to assess differences in the type of 53BP1 expression between non-exposed and exposed epidermal cells. Spearman's correlation coefficient by rank test was used to assess correlation between histological type of skin tumors and type of 53BP1 expression. A p-value of less than 0.05 was considered statistically significant.
Double-labeled immunofluorescence
To assess the co-localization of 53BP1-foci formation and p53 expression, 
Results
53BP1 expression in normal epidermis surrounding tumors
Of the 14 controls consisting of non-exposed normal epidermis, 13 cases (92.9%) expressed only stable type cells ( Figure 1A ), while one case (7.1%) showed stable type keratinocytes but also included a small number (up to 10%) of low DDR type in the basal layer. Of the other 8 controls consisting of sun-exposed normal epidermis, 2 cases (20%) expressed only stable type cells, while 5 cases (62.5%) showed stable type in more than 70% of keratinocytes but also had up to 30% of low DDR type ( Figure 1B ) in the basal layer. One other case (12.5%) also showed stable type in more than 70% of keratinocytes, but included up to 30% of high DDR type in the basal layer.
53BP1 expression in skin tumors
The results of the immunofluorescence of staining patterns for 53BP1 in each histological type of skin tumors are presented in Table 2 . Similar to the pattern observed for normal epidermal cells, all 10 of the non-exposed SK cases expressed only the stable type ( Figure 2A ). Of the 10 sun-exposed SK cases, 4 (40.0%) expressed only the stable type, while 6 (60.0%) showed stable type in more than 70% of tumor cells but also up to 30% of low DDR type ( Figure 2B ) mainly in basal layer.
In contrast to the normal epidermis and SK, of the 8 AK cases, 4 cases (50.0%) and 3 cases (37.5%) showed high DDR ( Figure 2C ) and low DDR types respectively in dysplastic cells, while only one case (12.5%) expressed the stable type. In the 9 BD cases, 2 cases (22.2%) showed low DDR type, 4 cases (44.4%) were of high DDR type, and 2 cases (22.2%) were of mixed high DDR and abnormal type ( Figure 2D ), while only one case (11.1%) expressed the stable type. Of the 9 SCC cases, 4 (44.4%) were of mixed low DDR and abnormal type and 5 (55.6%) were of the abnormal type ( Figure   2E ). Finally, of the 10 BCC cases, one case (10.0%) was of mixed low DDR and abnormal type, and 9 cases (90.0%) were of the abnormal type ( Figure 2F ).
The Mann-Whitney test revealed that DDR expression of 53BP1 was significantly higher in the sun-exposed epidermis than in the non-exposed epidermis (P=0.001).
Furthermore, Spearman's analysis revealed that the histological type of skin tumors was significantly correlated with type of 53BP1 expression (P<0.001).
Double-labeled immunofluorescence of 53BP1 and p53 expressions (Figure 3)/Ki-67 expressions (Figure 4)
Normal epidermis and SK expressed the stable or a low DDR type of 53BP1 immunoreactivity and only a few Ki-67 nuclear staining at the basal layer but no p53 nuclear staining. Discrete nuclear foci in a high DDR type of 53BP1 immunoreactivity were observed and were co-localized to dysplastic cells exhibiting p53 nuclear staining at the basal layer in AK. In BD, p53 nuclear staining was sparsely found in cancer cells which were distributed throughout the epidermal layer, and discrete nuclear foci of high DDR type of 53BP1 immunostaining were co-localized to p53-positive cancer cells. In SCC and BCC, high levels of abnormal type of 53BP1 and strong p53 immunoreactivity were observed in nuclei of cancer cells, and cells expressing the abnormal type of 53BP1 immunoreactivity were randomly distributed in lesions. Intense 53BP1 staining was not always co-localized with p53 overexpression in cancer cells. Furthermore, double staining of 53BP1 and Ki-67 demonstrated that discrete nuclear foci of 53BP1 immunostaining were not co-localized to Ki-67-positive dysplastic/cancer cells in AK/BD; whereas abnormal type of 53BP1 staining frequently expressed Ki-67 nuclear staining.
Discussion
Development of SCC of the skin is viewed as a multistep process, while BCCs are believed to develop de novo. (20) In skin carcinogenesis, AK is a well established precancerous skin lesion and it has been suggested that ~10% of these sun-induced lesions will develop into SCC. The number of discrete immunoreactive nuclear foci in DDR type of 53BP1 in the epidermis seems to increase in precancerous lesions. Furthermore, the abnormal type of 53BP1 immunoreactivity was restricted to malignancies including both CIS and invasive cancers. Similar results, which showed the differences in 53BP1 expression patterns during carcinogenesis, were also obtained in our recent study on thyroid tumors resected from patients. (17) Therefore, we submit that immunofluorescence analysis of 53BP1 expression can be a useful tool to estimate the level of GIN and, simultaneously, the malignant potential of human tumors such as skin and thyroid tumors.
Interestingly, the low DDR type of 53BP1 immunoreactivity was very rare in the non-exposed epidermis but frequently found in sun-exposed skin. Similarly, sun-exposed SK/benign skin tumor also frequently showed a low DDR type of 53BP1
immunoreactivity, but none of the non-exposed SK cases expressed the DDR type of 53BP1 immunoreactivity. Because the skin is the primary barrier in humans against the external environment, sun-exposed epidermis is continuously exposed to a low level of physical and chemical genotoxic agents such as UV and IR. Thus, a low DDR type of 53BP1 immunoreactivity in the sun-exposed epidermis may represent a minor genotoxic injury induced by external environmental factors.
P53 is activated by DDR-associated molecules, and is essential to control GIN and to suppress tumorigenesis. (22) The p53 mutation is the most prominent aberration in skin cancers, and it is now established that ~50% of all skin cancers show p53 mutations. (23) Double-labeled immunofluorescence was carried out to evaluate the association between the type of 53BP1 expression and p53 nuclear staining. In this study, although no p53 staining was observed in the epidermis and SK even at the sun-exposed sites which showed a low DDR type of 53BP1 immunoreactivity, AK showed both p53 nuclear staining and a high DDR type of 53BP1 immunoreactivity in dysplastic cells at the basal layer in the epidermis. The co-localization of p53 nuclear staining and 53BP 1 nuclear foci was also observed in BD. P53 mutations have been found in precanceous epidermis (24) (25) (26) and can be detected by immunohistochemistry. Indeed, 70% of immunohistochemical detections were shown to have an underlying mutation in the p53 gene. (25, 27) Because of the loss of p53 function based on gene mutation, environmental genotoxic agents may easily induce DSBs in precancerous lesion/CIS in skin.
Alternatively, because this study also demonstrated no co-localization of DDR type Actinic keratosis showed three or more discrete nuclear foci in dysplastic cells (high DRR type) (C). Bowen's disease showed several discrete nuclear foci mixed with intense and heterogeneous nuclear staining (mixed DRR and abnormal type) (D).
Squamous cell carcinoma (E) as well as basal cell carcinoma (F) exhibited intense and heterogeneous nuclear staining (abnormal type). 
